Purpose:
The purpose of this study was to investigate whether the follicle-stimulating hormone receptor (FSHR) gene p. Thr307Ala (c.919A>G, rs6165) and p. Asn680Ser (c.2039A>G, rs6166) polymorphisms are associated with susceptibility to polycystic ovary syndrome (PCOS).
Methods:
Genotyping was performed in 377 women with PCOS and 388 age-matched controls. Difference in the genotype distribution was assessed using a Fisher's exact or chi-square test, and continuous variables were compared using a Student's t test. To evaluate the association between the presence of PCOS status and SNP, logistic regression analyses were performed.
Results:
Linkage disequilibrium between the two polymorphisms was approximately complete (r = 99%). The genotype distributions of the PCOS group significantly differed from those of the control group (Thr/Thr, Thr/Ala, and Ala/Ala frequencies were 38.5, 46.7, and 14.9% for the PCOS group and 46.6, 45.4, and 8.0% for the controls, respectively, P = .005; Asn/Asn, Asn/Ser, and Ser/Ser frequencies were 39.5, 47.2, and 13.3% for the PCOS group and 46.4, 45.4, and 8.2% for the controls, respectively, P = .035). Using the wild-type genotypes as the references, the odds ratios that a woman has PCOS were 2.23 (95% confidence intervals 1.38-3.68) for the Ala/Ala genotype, 1.87 (95% confidence intervals 1.14-3.06) for the Ser/Ser genotype, and 1.96 (95% confidence intervals 1.19-3.24) for the homozygous variant combination (Ser/Ser-Ala/Ala). However, there were no significant differences in serum hormonal, ovarian, and metabolic markers according to each genotype.
Conclusions:
Findings of this study suggest a significant association between FSHR gene p. Thr307Ala or p. Asn680Ser coding sequence change and PCOS. The variant homozygote genotype results in a higher risk of PCOS.
Citing Articles
Follicle-Stimulating Hormone Receptor and Estrogen Receptor Gene Polymorphisms in Women With Discordant Follicle-Stimulating Hormone and Anti-Mullerian Hormone Levels.
Aktas G, Bertizlioglu M, Yilmaz S, Kebapcilar A, Celik C, Secilmis O
Cureus. 2024; 16(5):e60446.
PMID: 38883018
PMC: 11179686.
DOI: 10.7759/cureus.60446.
Polymorphisms in FSHR modulating susceptibility to polycystic ovary syndrome: an updated meta-analysis.
Kaur M, Singh S, Kaur A
J Ovarian Res. 2023; 16(1):183.
PMID: 37653412
PMC: 10472705.
DOI: 10.1186/s13048-023-01238-7.
Molecular Role of Asn680Ser and Asp37Glu Missense Variants in Saudi Women with Female Infertility and Polycystic Ovarian Syndrome.
Alshammary A, Alsobaie S, Alageel A, Aldakheel F, Ansar S, Alrashoudi R
Curr Issues Mol Biol. 2023; 45(7):5494-5514.
PMID: 37504264
PMC: 10378235.
DOI: 10.3390/cimb45070348.
Association Between Follicle-Stimulating Hormone Receptor (FSHR) rs6166 and Estrogen Receptor 1 (ESR1) rs2234693 Polymorphisms and Polycystic Ovary Syndrome Risk, Phenotype, and Reproductive Outcomes in an Infertile Portuguese Population.
Vieira I, Carvalho A, Almeida Reis S, Carreira A, Dias C, Fernandes S
Cureus. 2023; 15(3):e35690.
PMID: 37012960
PMC: 10066722.
DOI: 10.7759/cureus.35690.
Analyzing the Impact of FSHR Variants on Polycystic Ovary Syndrome-a Case-Control Study in Punjab.
Kaur M, Singh S, Kaur R, Beri A, Kaur A
Reprod Sci. 2023; 30(8):2563-2572.
PMID: 36821034
DOI: 10.1007/s43032-023-01194-z.
Beta-Meta: a meta-analysis application considering heterogeneity among genome-wide association studies.
Kim G, Lee Y, Park J, Kim D, Lee W
Genomics Inform. 2023; 20(4):e49.
PMID: 36617656
PMC: 9847376.
DOI: 10.5808/gi.22046.
Association of FSHR and DENND1A polymorphisms with polycystic ovary syndrome: a meta-analysis.
Larsen C, Kudela E, Biringer K
JBRA Assist Reprod. 2022; 27(1):60-70.
PMID: 36350975
PMC: 10065767.
DOI: 10.5935/1518-0557.20220043.
An update on polycystic ovary syndrome: A review of the current state of knowledge in diagnosis, genetic etiology, and emerging treatment options.
Islam H, Masud J, Islam Y, Haque F
Womens Health (Lond). 2022; 18:17455057221117966.
PMID: 35972046
PMC: 9386861.
DOI: 10.1177/17455057221117966.
Pilot study on evaluation and determination of the prevalence of Polycystic Ovarian Syndrome (PCOS) associated gene markers in the South Indian population.
Ramanathan B, Murugan J, Velayutham K
Indian J Endocrinol Metab. 2022; 25(6):551-558.
PMID: 35355907
PMC: 8959196.
DOI: 10.4103/ijem.ijem_340_21.
A GWAS in Idiopathic/Unexplained Infertile Men Detects a Genomic Region Determining Follicle-Stimulating Hormone Levels.
Schubert M, Perez Lanuza L, Woste M, Dugas M, Carmona F, Palomino-Morales R
J Clin Endocrinol Metab. 2022; 107(8):2350-2361.
PMID: 35305013
PMC: 9282256.
DOI: 10.1210/clinem/dgac165.
Replication study and meta-analysis of selected genetic variants and polycystic ovary syndrome susceptibility in Asian population.
Wan P, Meng L, Huang C, Dai B, Jin Y, Chai L
J Assist Reprod Genet. 2021; 38(10):2781-2789.
PMID: 34403018
PMC: 8581112.
DOI: 10.1007/s10815-021-02291-1.
Frequency of night shift and menstrual cycle characteristics in Japanese nurses working under two or three rotating shifts.
Mayama M, Umazume T, Watari H, Nishiguchi S, Moromizato T, Watari T
J Occup Health. 2020; 62(1):e12180.
PMID: 33211393
PMC: 7676323.
DOI: 10.1002/1348-9585.12180.
ACTUALITIES IN MUTATIONS OF LUTEINIZING HORMONE (LH) AND FOLLICLE-STIMULATING HORMONE (FSH) RECEPTORS.
Gheorghiu M
Acta Endocrinol (Buchar). 2019; -5(1):139-142.
PMID: 31149075
PMC: 6535329.
DOI: 10.4183/aeb.2019.139.
Follicle Stimulating Hormone Receptor (FSHR) Polymorphisms and Polycystic Ovary Syndrome (PCOS).
Laven J
Front Endocrinol (Lausanne). 2019; 10:23.
PMID: 30809190
PMC: 6379247.
DOI: 10.3389/fendo.2019.00023.
Variant Alleles of the , and Genes Are Associated With Polycystic Ovary Syndrome Risk in a Chinese Population: A Case-Control Study.
Jiao X, Chen W, Zhang J, Wang W, Song J, Chen D
Front Endocrinol (Lausanne). 2018; 9:504.
PMID: 30214429
PMC: 6125305.
DOI: 10.3389/fendo.2018.00504.
Potential genetic polymorphisms predicting polycystic ovary syndrome.
Chen Y, Fang S
Endocr Connect. 2018; 7(5):R187-R195.
PMID: 29622662
PMC: 5937197.
DOI: 10.1530/EC-18-0121.